A Phase II Trial of Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Non-Metastatic Pancreatic Adenocarcinoma: Cancer and Leukemia Group B (CALGB) 80003
- Citation:
- Cancer vol 117 (12) 2620-2628
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 800
- Children:
- None
- Pharmas:
- Grants:
- CA77597, CA11789, CA77406, U10 CA033601-23, U10 CA031946-23, CA32291, CA03927, U10 CA031946, U10 CA033601, CA59518, U10 CA033601-22, CA45389, CA45808, CA35279, CA12046, U10 CA031946-22, CA16450, CA77440, CA45564, CA04326, U10 CA033601-25, CA47559, CA47642, U10 CA031946-21, CA45418, CA77658, U10 CA031946-20, U10 CA033601-24, CA07968
- Corr. Author:
- Authors:
- Harvey J. Mamon Donna Niedzwiecki Donna Hollis Benjamin R. Tan Robert J. Mayer Joel E. Tepper Richard M. Goldberg A. William Blackstock Charles S. Fuchs
- Networks:
- Study
- CALGB-80003
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- pancreatic cancer, gemcitabine, 5-fluorouracil, radiation, combined modality therapy